CymitQuimica logo

Meayamycin B

CAS:

Ref. 3D-EM179115

ne
To inquire
Meayamycin B
Biosynth

Product Information

Name:Meayamycin B
Brand:Biosynth
Description:Meayamycin B is a synthetic macrolide, a complex organic compound, which is derived from the natural product FR901464. This compound functions as an antagonist of the spliceosome, the cellular machinery responsible for pre-mRNA splicing. By binding to specific components of the spliceosome, Meayamycin B disrupts the splicing process, leading to the accumulation of unspliced precursor mRNA. This action effectively induces apoptosis in cancer cells, making it a notable candidate for cancer therapy research. The use of Meayamycin B is predominantly seen in molecular biology and cancer research settings. Its ability to precisely target and disrupt gene expression pathways provides researchers with a valuable tool to study RNA processing in cells. Additionally, due to its pro-apoptotic effect on cancerous cells, it is explored for therapeutic developments in oncology. The unique mechanism of action of Meayamycin B offers insights into spliceosomal functions and potential interventions in diseases characterized by aberrant RNA splicing.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:576.72 g/mol
Formula:C31H48N2O8
Purity:Min. 95%

Technical inquiry about: Meayamycin B

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.